HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial.

Abstract
Obesity is known to be influenced by a number of genes, including the β3 subunit of G protein (GNB3), β3-adrenergic receptor (ADRB3), uncoupling protein 2 (UCP2), and peroxisome proliferator activated receptor gamma (PPARγ). The single nucleotide polymorphisms (SNPs) of the above genes, such as GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala, are associated with obesity and body mass index. The present study evaluates the impact of Bofutsushosan, a traditional Eastern Asian herbal medicine with known anti-obesity properties, on obese subjects according to the presence of the above-mentioned SNPs. Upon randomization, the volunteers were allocated to receive Bofutsushosan (n=55) or placebo (n=56) treatments for 8 weeks. Following the treatment schedule, significant reductions in total cholesterol and significant improvement in the Korean version of obesity-related quality of life scale were seen in the Bofutsushosan-treated group, but not in placebo. Bofutsushosan exerted significant anti-obesity effects on a number of parameters in the carriers of the GNB3-825T allele, but only on waist circumference in the GNB3-C/C homozygote. Significant anti-obesity impact of Bofutsushosan was also seen on a number of obesity-indices in both ADRB3-Arg64 carriers and ADRB3-Trp64 homozygotes, as well as in UCP2-D/D carriers, but not in UCP2-D/I+I/I variants. The effect of Bofutsushosan was more pronounced in PPARγ-Pro/Pro genotype compared to PPARγ-Pro/Ala variants. Thus, the results revealed differential responses of the subjects to the anti-obesity effects of Bofutsushosan treatment according to the polymorphism of the vital obesity-related genes. Our study provides new insight into individualized clinical applications of Bofutsushosan for obesity.
AuthorsJunghyun Park, Shambhunath Bose, Sun-Woo Hong, Dong-Ki Lee, Jae-Wook Yoo, Chi-Yeon Lim, Myeongjong Lee, Hojun Kim
JournalJournal of medicinal food (J Med Food) Vol. 17 Issue 5 Pg. 558-70 (May 2014) ISSN: 1557-7600 [Electronic] United States
PMID24827746 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • 3' Untranslated Regions
  • ADRB3 protein, human
  • Anti-Obesity Agents
  • Drugs, Chinese Herbal
  • G-protein beta3 subunit
  • Ion Channels
  • Mitochondrial Proteins
  • PPAR gamma
  • Placebos
  • Receptors, Adrenergic, beta-3
  • UCP2 protein, human
  • Uncoupling Protein 2
  • bofu-tsusho-san
  • Heterotrimeric GTP-Binding Proteins
Topics
  • 3' Untranslated Regions
  • Adult
  • Anti-Obesity Agents (therapeutic use)
  • Body Mass Index
  • Double-Blind Method
  • Drugs, Chinese Herbal (therapeutic use)
  • Genotype
  • Heterotrimeric GTP-Binding Proteins (genetics)
  • Humans
  • Ion Channels (genetics)
  • Middle Aged
  • Mitochondrial Proteins (genetics)
  • Mutation
  • Obesity (drug therapy, genetics)
  • PPAR gamma (genetics)
  • Placebos
  • Polymorphism, Single Nucleotide
  • Receptors, Adrenergic, beta-3 (genetics)
  • Republic of Korea
  • Uncoupling Protein 2
  • Waist Circumference

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: